.jpg?format=webp&width=780)
The objective of this study was to evaluate the cost-utility of MITs (WVTT and PUL) compared to pharmacotherapy as an initial treatment for patients with moderate-to-severe BPH. WVTT is an effective and cost-saving procedure and may be an appropriate first-line alternative to pharmacotherapy for moderate-to-severe BPH patients who seek faster improvement and have no lifelong commitment to daily medications.
Like
Save
Share